| http://www.w3.org/ns/prov#value | - lower than expected sales growth of our high-value pharmaceutical packaging products, of CZ products and of other proprietary safety and administration devices; maintaining or improving production efficiencies and overhead absorption; dependence on third-party suppliers and partners, some of which are single-source suppliers of critical materials and products, including our Japanese partner and af
|
